Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 200

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Novel methodologies for biomarker discovery in atherosclerosis

Open access
Hoefer, Imo E., Steffens, Sabine, Ala-Korpela, Mika, Bäck, Magnus, Badimon, Lina, Bochaton-Piallat, Marie-Luce, Boulanger, Chantal M., Caligiuri, Giuseppina, Dimmeler, Stefanie, Egido, Jesus, Evans, Paul C., Guzik, Tomasz, Kwak, Brenda R., Landmesser, Ulf, Mayr, Manuel, Monaco, Claudia, Pasterkamp, Gerard, Tuñón, Jose, Weber, Christian · 2015 · European Heart Journal

Abstract

Identification of subjects at increased risk for cardiovascular events plays a central role in the worldwide efforts to improve prevention, prediction, diagnosis, and prognosis of cardiovascular disease and to decrease the related costs. Despite their high predictive value on population level, traditional risk factors fail to fully predict individual risk. This position paper provides a summary of current vascular biomarkers other than the traditional risk factors with a special focus on the emerging -omics technologies. The definition of biomarkers and the identification and use of classical biomarkers are introduced, and we discuss the limitations of current biomarkers such as high sensitivity C-reactive protein (hsCRP) or N-terminal pro-brain natriuretic peptide (NT-proBNP). This is complemented by circulating plasma biomarkers, including high-density lipoprotein (HDL), and the conceptual shift from HDL cholesterol levels to HDL composition/function for cardiovascular risk assessment. Novel sources for plasma-derived markers include microparticles, microvesicles, and exosomes and their use for current omics-based analytics. Measurement of circulating micro-RNAs, short RNA sequences regulating gene expression, has attracted major interest in the search for novel biomarkers. Also, mass spectrometry and nuclear magnetic resonance spectroscopy have become key complementary technologies in the search for new biomarkers, such as proteomic searches or identification and quantification of small metabolites including lipids (metabolomics and lipidomics). In particular, pro-inflammatory lipid metabolites have gained much interest in the cardiovascular field. Our consensus statement concludes on leads and needs in biomarker research for the near future to improve individual cardiovascular risk prediction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehv236

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 200

Metadata

Authors
Hoefer, I. E., Steffens, S., Ala-Korpela, M., Bäck, M., Badimon, L., Bochaton-Piallat, M.-L., Boulanger, C. M., Caligiuri, G., Dimmeler, S., Egido, J., Evans, P. C., Guzik, T., Kwak, B. R., Landmesser, U., Mayr, M., Monaco, C., Pasterkamp, G., Tuñón, J., & Weber, C.
Venue
European Heart Journal
Published
2015-06-05
Volume
36
Issue
39
Pages
2635-2642
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2246715603
Cited by
200
References
22
FWCI
24.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel methodologies for biomarker discovery in atherosclerosis. https://app.cochat.ai/papers/10.1093/eurheartj/ehv236
The paper
Hoefer, I. E., Steffens, S., Ala-Korpela, M., Bäck, M., Badimon, L., Bochaton-Piallat, M.-L., Boulanger, C. M., Caligiuri, G., Dimmeler, S., Egido, J., Evans, P. C., Guzik, T., Kwak, B. R., Landmesser, U., Mayr, M., Monaco, C., Pasterkamp, G., Tuñón, J., & Weber, C. (2015). Novel methodologies for biomarker discovery in atherosclerosis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv236

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.